Advertisement

ADVERTISEMENT

Edan Stanley

Russell Spjut
Podcasts
PDTs vs DTx: What’s the Difference?
03/21/2023
Russell Spjut, PharmD, director, formulary management, Magellan Rx Management, offers some insight on the difference between digital therapeutics terminology and the current landscape for these products.
Russell Spjut, PharmD, director, formulary management, Magellan Rx Management, offers some insight on the difference between digital therapeutics terminology and the current landscape for these products.
Russell Spjut, PharmD, director,...
03/21/2023
First Report Managed Care
News
Avoiding Anticholinergic Burden in Patients With Movement Disorders
03/20/2023
Researchers recently conducted a roundtable, survey, and HEOR study to develop more standardized recommendations for the use of anticholinergic medications for patients with movement disorders.
Researchers recently conducted a roundtable, survey, and HEOR study to develop more standardized recommendations for the use of anticholinergic medications for patients with movement disorders.
Researchers recently conducted a...
03/20/2023
Annals of Long-Term Care
News
Staffing, Limited Resources to Address Mental Health Remain Top Challenges for SNFs
03/15/2023
“Nationally, SNFs implemented a wide array of care delivery approaches, but challenges with staffing and limited resources to address patients' social and mental health needs were dominant,” authors said.
“Nationally, SNFs implemented a wide array of care delivery approaches, but challenges with staffing and limited resources to address patients' social and mental health needs were dominant,” authors said.
“Nationally, SNFs implemented a...
03/15/2023
Annals of Long-Term Care
Alex Kilgore, PharmD, product manager, global products & solutions, AmerisourceBerge
Interview
Early Commercialization Planning Is Key for PDT Success, Patient Access
03/15/2023
“There is need for additional support to keep the patient engaged and empowered to take ownership and an active role in their health care. I think digital therapeutics are a way to start to bridge that gap where we can have that continuous...
“There is need for additional support to keep the patient engaged and empowered to take ownership and an active role in their health care. I think digital therapeutics are a way to start to bridge that gap where we can have that continuous...
“There is need for additional...
03/15/2023
First Report Managed Care
Craig Gravina, chief technology officer, ObvioHealth
Podcasts
Navigating the Path to Approval for PDTs Using Decentralized Clinical Trials
02/27/2023
Craig Gravina, chief technology officer, ObvioHealth, sheds some light on the current digital therapeutics landscape, including regulatory challenges, the prescription DTx model, and solutions to improve clinical trial research.
Craig Gravina, chief technology officer, ObvioHealth, sheds some light on the current digital therapeutics landscape, including regulatory challenges, the prescription DTx model, and solutions to improve clinical trial research.
Craig Gravina, chief technology...
02/27/2023
First Report Managed Care
News
Humana Announces Plan to Leave Employer Market
02/23/2023
In a press release today, Humana shares intention to depart the employer group medical products business to focus on government-funded programs.
In a press release today, Humana shares intention to depart the employer group medical products business to focus on government-funded programs.
In a press release today, Humana...
02/23/2023
First Report Managed Care
News
FDA Approves Zanubrutinib for Adults With Chronic Lymphocytic Leukemia
01/20/2023
The approval of BTK Inhibitor zanubrutinib for adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma is based on two global phase 3 clinical trials.
The approval of BTK Inhibitor zanubrutinib for adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma is based on two global phase 3 clinical trials.
The approval of BTK Inhibitor...
01/20/2023
First Report Managed Care
News
HHS Announces Medicare Drug Price Negotiation Program Deadlines
01/12/2023
“For the first time in history, because of the Inflation Reduction Act, Medicare will have the ability to negotiate prescription drug prices,” said HHS in a press release.
“For the first time in history, because of the Inflation Reduction Act, Medicare will have the ability to negotiate prescription drug prices,” said HHS in a press release.
“For the first time in history,...
01/12/2023
First Report Managed Care
News
2023 Marketplace Open Enrollment Up 13% From Last Year
01/11/2023
According to a press release from the Centers for Medicare & Medicaid Services, the open enrollment period for ACA Marketplace plans is seeing record-breaking increases.
According to a press release from the Centers for Medicare & Medicaid Services, the open enrollment period for ACA Marketplace plans is seeing record-breaking increases.
According to a press release...
01/11/2023
First Report Managed Care
News
Analyzing Drug-Induced Fall Risk Data Among Older Adults
12/28/2022
“…the risk level of drug-induced falls should be considered to optimize drug therapy in clinical practice,” said researchers.
“…the risk level of drug-induced falls should be considered to optimize drug therapy in clinical practice,” said researchers.
“…the risk level of drug-induced...
12/28/2022
Annals of Long-Term Care

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

March 23 ⁠–⁠ March 24
April 27 ⁠–⁠ April 28
Great Debates & Updates in Diabetic Foot
November 30 ⁠–⁠ December 2
November 27 ⁠–⁠ November 29
AIBD logo
Psych Congress Primary Care Online Series
December 12 ⁠–⁠ December 13
May 13 ⁠–⁠ May 14
February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use